Table 2

Immunohistochemical expression of GCET1 in major human lymphoma subtypes

DiagnosisCases studied, no.GCET1+, no. (%)
B-cell lymphomas 
    Chronic lymphocytic leukemia/small lymphocytic lymphoma 20 0 (0) 
    Splenic marginal zone lymphoma 0 (0) 
    Mantle cell lymphoma, classic variant 19 0 (0) 
    Burkitt lymphoma 19 7 (37) 
    Follicular lymphoma 89 82 (92) 
    Diffuse large B-cell lymphoma* 72 34 (47) 
    T-cell /histiocyte-rich B-cell lymphoma 13 7 (54) 
Hodgkin lymphoma 
    Nodular lymphocyte predominant Hodgkin lymphoma 40 38 (95) 
    Lymphocyte rich classical Hodgkin lymphoma 15 2 (13) 
    Other classical Hodgkin lymphoma (mixed cellularity and nodular sclerosis) 56 0 (0) 
T-cell lymphoma, peripheral, not otherwise specified 18 0 (0) 
DiagnosisCases studied, no.GCET1+, no. (%)
B-cell lymphomas 
    Chronic lymphocytic leukemia/small lymphocytic lymphoma 20 0 (0) 
    Splenic marginal zone lymphoma 0 (0) 
    Mantle cell lymphoma, classic variant 19 0 (0) 
    Burkitt lymphoma 19 7 (37) 
    Follicular lymphoma 89 82 (92) 
    Diffuse large B-cell lymphoma* 72 34 (47) 
    T-cell /histiocyte-rich B-cell lymphoma 13 7 (54) 
Hodgkin lymphoma 
    Nodular lymphocyte predominant Hodgkin lymphoma 40 38 (95) 
    Lymphocyte rich classical Hodgkin lymphoma 15 2 (13) 
    Other classical Hodgkin lymphoma (mixed cellularity and nodular sclerosis) 56 0 (0) 
T-cell lymphoma, peripheral, not otherwise specified 18 0 (0) 
*

GC: 21/31+; non-GC: 3/21+ (according to Hans et al19 ).

Close Modal

or Create an Account

Close Modal
Close Modal